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Abstract
Background: Imiquimod (IQ) is known as an agonist of Toll-like receptor 7 (TLR7) and is widely used to treat
various infectious skin diseases. However, it causes severe itching sensation as its side effect. The precise
mechanism of how IQ causes itching sensation is unknown. A recent report suggested a molecular target of IQ as
TLR7 expressed in dorsal root ganglion (DRG) neurons. However, we recently proposed a TLR7-independent
mechanism, in which the activation of TLR7 is not required for the action of IQ in DRG neurons. To resolve this
controversy regarding the involvement of TLR7 and to address the exact molecular identity of itching sensation by
IQ, we investigated the possible molecular target of IQ in DRG neurons.
Findings: When IQ was applied to DRG neurons, we observed an increase in action potential (AP) duration and
membrane resistance both in wild type and TLR7-deficient mice. Based on these results, we tested whether the
treatment of IQ has an effect on the activity of K
+ channels, Kv1.1 and Kv1.2 (voltage-gated K
+ channels) and TREK1
and TRAAK (K2P channels). IQ effectively reduced the currents mediated by both K
+ channels in a dose-dependent
manner, acting as an antagonist at TREK1 and TRAAK and as a partial antagonist at Kv1.1 and Kv1.2.
Conclusions: Our results demonstrate that IQ blocks the voltage-gated K
+ channels to increase AP duration and
K2P channels to increase membrane resistance, which are critical for the membrane excitability of DRG neurons.
Therefore, we propose that IQ enhances the excitability of DRG neurons by blocking multiple potassium channels
and causing pruritus.
Findings
Imiquimod (IQ) is widely used to treat various skin dis-
eases such as molluscum contagiosum, basal cell carci-
noma, and Bowen’s disease [1]. Topical application of
the compound is currently approved for treatment of
genital warts, a highly contagious sexually transmitted
disease caused by human papillomavirus [1-5]. It is
believed that IQ modulates immune responses via Toll-
like receptor 7 (TLR7) releasing IFN-a/b and proinflam-
matory cytokines [6]. Nevertheless, the exact mechanism
of how IQ activates the immune system is not fully
understood. Despite its clinical importance, the most
prominent side effect of IQ is pruritus, e.g. itching sen-
sation [7,8]. The mechanism of how IQ causes itching
sensation has remained unknown.
Recently we and others reported that IQ-induced
depolarization in dorsal root ganglion (DRG) neurons
leads to itching behavior [7,8]. Even though these two
studies agreed upon IQ’s action on the cellular and
behavioral level, there was a profound discrepancy on
the molecular target of IQ. The study by Liu et al.
reported that membrane depolarization caused by IQ
required TLR7 to generate action potentials (APs) and
* Correspondence: sjlee87@snu.ac.kr; cjl@kist.re.kr
1WCI Center for Functional Connectomics, Korea Institute of Science and
Technology, Seoul, 136-791, Republic of Korea
2Department of Neuroscience, Dental Research Institute, and Brain Korea 21,
School of Dentistry, Seoul National University, Seoul, 110-749, Republic of
Korea
Full list of author information is available at the end of the article
Lee et al. Molecular Pain 2012, 8:2
http://www.molecularpain.com/content/8/1/2 MOLECULAR PAIN
© 2012 Lee et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.to induce itching behavior [8]. On the contrary, our
study independently demonstrated that the action of IQ
does not require the TLR7 pathway [7]. In this study,
we showed that IQ caused depolarization and AP firing
in DRG neurons of both wild type (WT) and TLR7
knock out (KO) mice. Our results suggested that IQ
induced depolarization and AP firing, not by TLR7 sig-
nal transduction, but by the direct effect on other chan-
nels [7].
DRG neurons express many types of potassium chan-
nels including voltage-gated (Kv), inwardly rectifying
(Kir), Ca
2+-activated (KCa) and background (leak, K2P)K
+ channels. These channels contribute to the regulation
of membrane repolarization, resting membrane poten-
tial, frequency of firing, and excitability of sensory neu-
rons [9,10]. Among various K
+ channels, Kv channels
play a crucial role in returning the depolarized cell to
the resting state, and the inhibition of these channels
leads to AP broadening (for review see [11]). In addi-
tion, DRG neurons express at least eight K2P channel
subtypes as reported at the mRNA transcript level
[12,13]. K2P channels help to set, and stabilize the rest-
ing membrane potential and closing of these channels
leads to membrane depolarization [14]. In our prelimin-
ary analysis of the results, we found an increase in
membrane resistance and duration of AP during IQ
treatment. Therefore, we systematically tested the possi-
ble molecular target of IQ on K
+ channels. Our results
demonstrate that IQ effectively inhibits Kv and K2P
channels in DRG neurons.
Our previous results and initial examination of the
action of IQ on AP waveform inspired us to closely
monitor the changes of AP during the treatment of IQ.
F i r s tw ec o m p a r e dI Qe v o k e df i r i n go fA Po nW Ta n d
TLR7 KO mice. Using whole cell recording under cur-
rent clamp mode, we obtained action potential firing
from DRG neuron induced by 50 pA current injection.
Interestingly the half-width duration of AP from WT
DRG neurons increased significantly by a twofold during
the bath application of 20 μg/ml IQ (from 4.68 ± 0.53
ms (n = 10) to 10.28 ± 0.19 ms (n = 6), P < 0.01). Inter-
estingly, this increase in AP duration by IQ was also
observed in the DRG neurons of TLR7 KO (from 4.60 ±
0.95 ms (n = 7) to 9.89 ± 1.04 ms (n = 9), P < 0.01)
(Figure 1A).
Then, we examined the change of input resistance by
IQ in WT. The measurement of input resistance by the
injection of negative curren ti n d i c a t e dt h a tb a c k g r o u n d
leak channel activity was altered by IQ treatment (Figure
1B). Membrane resistance of WT and TLR7 KO was
s i m i l a r( 5 9 3±5 2 . 3 9M Ω (n = 6) in WT control; 531 ±
151.99 MΩ (n = 6) in TLR7 KO) and IQ significantly
increased membrane resistance in WT (165.66 ± 13.82%
(n = 7), P < 0.01) and KO (128.11 ± % (n = 9), P <
0.05). These results indicated that IQ depolarizes the
membrane potential and increase AP duration in DRG
neurons, and that these effects might not be due to the
activation of TLR7 signaling pathway. Rather, these
results strongly suggested IQ’s direct targeting on ion
channel(s), in particular, potassium channels.
Kv1.1 and Kv1.2 are the predominant voltage gated K
+
channels in DRG neuron that regulates the time course
of AP waveform. Because we observed that IQ increased
the duration of AP, we investigated whether IQ has any
direct effect on the activity of Kv1.1 and Kv1.2 in hetero-
logous expression system. Under whole-cell patch vol-
tage clamp mode, inward and outward K
+ current
through Kv1.1 and Kv1.2 channels were elicited by a ser-
ies of voltage steps (from +100 mV to -100 mV with 20
mV step) to examine the effect of IQ on the voltage
gated channels expressed in COS7 cells. The activity of
both Kv1.1 and Kv1.2 were blocked by IQ treatment in a
dose-dependent manner. Kv1.1-mediated current was
concentration-dependent. It was effectively inhibited by
IQ at the concentrations of 10, 100 and 500 μM. The
remaining currents were measured as 91.87 ± 2.94% (n
= 9), 60.36 ± 3.26% (n = 11) and 48.49 ± 5.49% (n = 9),
respectively (Figure 2A). Similarly Kv1.2-mediated cur-
rent also was dose-dependently blocked by IQ at 1, 10,
100, and 500 μM. The remaining currents were mea-
sured as 91.07 ± 2.87% (n = 4), 73.45 ± 5.43% (n = 7),
42.93 ± 5.48% (n = 7), and 33.01 ± 4.55% (n = 7),
respectively (Figure 2B). The resulting concentration-
response relationship showed that the efficacy of IQ on
Kv1.1 and Kv1.2 is not completed at saturating concen-
trations, suggesting that IQ is acting as a partial antago-
nist. The half-maximal concentration, IC50 of IQ on
Kv1.1 and Kv1.2 activity was determined as 39.2 μM
(Hill Coefficient = 1.26) and 21.32 μM (Hill Coefficient
= 0.7262) respectively.
To test IQ’s effect on the leak current, we recorded
the activity of heterologously expressed TREK1 and
TRAAK, one of the major K2P channels expressed in
DRG neurons. Whole cell currents elicited by voltage
ramps from +100 mV to -100 mV for each concentra-
tion of IQ were recorded and analyzed for the degree of
block. Figure 3A and 3C show the representative traces
of TREK1 and TRAAK-mediated currents in different
concentrations of IQ. The traces were induced by ramp-
ing membrane potential to obtain instant current-vol-
tage relationship (see Materials and Methods). We
f o u n dt h a tI Qr e a d i l yb l o c k e dT R E K 1a n dT R A A K -
mediated currents in a concentration-dependent manner
(for TREK1, 1 μM: 1.5 ± 6.75%, 10 μM: 18.0 ± 7.40%,
50 μM: 44.3 ± 5.57%, 100 μM: 56.5 ± 5.99%, and 300
μM: 66.4 ± 4.07% (Figure 3B); for TRAAK, 1 μM: 6.6 ±
2.04%, 30 μM: 24.8 ± 6.85%, 100 μM: 37.5 ± 11.14%,
and 300 μM: 60.2 ± 11.01% (Figure 3D)). The calculated
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Page 2 of 6Figure 1 Effects of IQ on AP duration and membrane resistance of DRG neurons in WT and TLR7 KO mice. A. Representative trace of AP
of DRG neuron from WT and TLR7 KO before and after application of IQ. Bar graph indicates the average of AP duration of DRG neurons with or
without IQ treatment from WT and TLR7 KO mice. B. Left column shows the representative example of change of membrane resistance induced
by injection of negative current. Average effect of IQ on membrane resistance compared with WT and KO is shown as bar graph. Protocol for
AP induction and membrane resistance by current injection was shown in bottom of traces of A and C. The number in each bar indicates the
number of neurons. Error bars indicate S.E.M. (**, P > 0.01).
Figure 2 Partial inhibitory effect of IQ on Kv1.1 and Kv1.2 activity. A, C Effect of different concentrations of IQ on Kv1.1 (A) and Kv1.2 (C)
currents induced by a voltage step. Protocol of voltage step shown below the traces. B, D. Average % of remaining currents of Kv1.1 (B) and
Kv1.2 (D) during IQ (1, 10, 100 and 500 μM) application. Concentration-response relationship was obtained by fitting with logistic function. IC50 of
IQ on Kv1.1 and Kv1.2 is 39.2 μM and 21.32 μM, respectively. Error bars indicate S.E.M.
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Page 3 of 6IC50 of IQ on TREK1 and TRAAK currents was 181.7
μMa n d8 1 . 1μM after curve fitting. These results indi-
cated that IQ directly blocks TREK1 and TRAAK chan-
nels, which provide the background leakage current in
DRG neurons.
Clinically, IQ has been known as a topically active
immunomodulatory agent that is formulated as a 5%
cream for application by the patient of skin diseases. IQ
5% cream is generally well tolerated by immunocompe-
tent and HIV-infected patients. Local skin reactions
(mainly mild or moderate), including erythema, itching
and burning, are the most commonly reported adverse
events, occurring in < or = 67% of patients applying IQ
5% cream 3 times a week [1,5]. So far, the mechanism
of how IQ causes the adverse side-effects has been
unknown. In this study, we demonstrate, for the first
time, that IQ inhibits Kv1.1and Kv1 . 2a n dT R E K 1a n d
TRAAK. These results can explain the IQ’s action of
increasing the excitability of sensory neurons. This, in
turn, could explain the ability of IQ to induce itching
sensation.
In our previous study, we described various actions of
IQ such as membrane depolarization, action potential
firing, increase in intracellular Ca
2+ concentration, and
itching behavior [7]. We found that IQ can directly
excite DRG neurons most likely by blocking Kv and K2P
channels. For IQ-induced Ca
2+ response, we found that
it was not altered by external Ca
2+, but was completely
blocked by the application of 2-aminoethoxydiphenyl
borate (2-APB), an inhibitor of inositol trisphosphate
receptor (IP3R) [7]. Therefore, IQ seems to act on many
molecular targets including Ca
2+ release channels as
well as various potassium channels in sensory neurons.
Our data from the heterologous expression system using
Figure 3 Antagonistic effect of IQ on TREK1 and TRAAK, K2P channel. A, C Inhibitory effect of IQ on TREK1 (A) and TRAAK (C) channels as
shown by instant I-V relationship. B, D Average % of remaining currents at each concentration of IQ on TREK1 (B) and TRAAK (D) channels.
Fitted line was used to obtain IC50 (TREK1, 81.1 μM; TRAAK, 181.7 μM) of IQ on K2P channels. Error bars indicate S.E.M.
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are TLR7-independent, and suggest that it rather
directly acts on potassium channels in sensory neurons.
In this study, we have not characterized the putative
cross-talk between IQ-induced Ca
2+ increase and potas-
sium channel block. Thus, at this point, it is not clear
whether IQ inhibits potassium channels independently
of intracellular Ca
2+ increase, which needs to be clarified
in the future studies.
Although there are many channels contributing to
membrane depolarization and generation of action
potential in neurons, various K
+ channels exert an
important role in repolarizing membrane potentials and
maintaining AP duration. Among many types of potas-
sium channels expressed in DRG neurons, Kv1.1, Kv1.2,
Kvb2.1 and Kv1.4 were reported as voltage-gated chan-
nels that regulate membrane repolarization, resting
membrane potential, frequency of firing, and neuro-
transmitter release in sensory neurons [9]. Background
K
+ channels have been implicated in various important
physiological functions including mechano-, lipid-, acid-
and possibly oxygen-sensing in specialized cells. In neu-
rons, it was reported that these channels help to set and
stabilize the resting membrane potential [14]. Our
results demonstrate that IQ blocks K
+ channels (Kv and
K2P), thereby enhancing the excitability of DRG neurons.
Our results provide a possible explanation for how IQ
causes pruritius. Yet, the detailed mechanism of how IQ
can lead to itching sensation by blocking various potas-
sium channels remains to be uncovered.
Materials and methods
Animals
All experimental procedures described below were per-
formed in accordance with the institutional guidelines of
KIST (Seoul, Korea). TLR7-deficient mice were pur-
chased from Jackson Laboratory. They were crossed
with wild-type C57BL/6 (2-month-old, Charles River) to
produce heterozygous mice. The resultant heterozygous
mice were used as mating pairs. More detail methods
maintaining TLR7 strain were previously described [7].
Specifically, the Jackson Laboratory TLR7 mouse was
originally established by R. Flavell’s laboratory (Yale
University, New Haven, CT). Littermates or age-
matched mice were generally used as wild type controls.
Preparation of Primary DRG Cell Culture
DRG neurons were prepared from adult mice (~2
month old) by methods similar to those described pre-
viously [15,16]. Briefly, DRG from all spinal levels were
collected in Ca
2+/Mg
2+-free Hanks’ balanced salt solu-
tion (HBSS; Invitrogen) and treated with enzyme solu-
tion containing 60 units of papain/cystein (0.33 mg/mL),
5 mg/mL of Dispase, and 4 mg/mL of collagenase
(Gibco) for 10 min at 37°C, respectively. Following tri-
turation and centrifugation, the dispersed cells were
resuspended in DMEM/F12 culture media containing
10% FBS [nerve-growth factor (NGF) or glial cell line-
derived neurotropic factor (GDNF) was not included in
culture medium] and were plated in 35-mm poly D-
lysine precoated glass-bottomed dishes (MatTek) coated
with laminin. Cultures were maintained at 37°C in a
humidified atmosphere of 95% air and 5% CO2 and
assayed after 16-20 h.
DRG neuron whole cell recording
Acutely dissociated DRG neurons were obtained from
C57BL/6 and TLR7 KO mice (8-10 wks) and attached
to coverslips for recording. Before recording, coverslips
were incubated in media for at least 1 h. DRG neuron
recordings were performed in HEPES buffer of the fol-
lowing composition (in mM): 10 HEPES, 150 NaCl, 10
KCl, 2 CaCl2,2M g C l 2, 5.5 glucose, and 22 sucrose (pH
7.4). Under the upright microscope, whole-cell patch
recordings were obtained from acute-isolate DRG neu-
rons in voltage-clamp mode and switched current-clamp
configuration for recordings with an Axopatch 700B
(Molecular Devices). Pipette resistance ranged from 3 to
6M Ω. The internal solution consisted of (in mM) 140
K-gluconate, 10 Hepes, 7 NaCl, 4 Mg-ATP, and 0.3
Na3-GTP (pH 7.4). Firing properties were established
for 1,000-ms duration by applying current injection
from -100 to 350 pA with 50 pA increase. The cells
with access resistance less than 20 MΩ that showed less
than 20% change during the recordings were included in
this study. Records were filtered at 5 kHz and digitized
at 2-5 kHz with a Digidata 1322A (Molecular Devices)
analog-to-digital board. Data were analyzed and plotted
with the pClamp (Molecular Devices), Mini Analysis
Program (Synaptosoft), and Origin. All data were col-
lected at room temperature (23-26°C).
COS7 Cell Culture and Transfection of plasmid DNA
COS 7 cells are cultured in high-glucose DMEM (Invitro-
gen) containing 10% FBS, and 100 U/ml penicillin/strep-
tomycin, and maintained at 37°C in a 5% CO2 incubator.
Transfections of plasmid DNA containing rat Kv1.1
(Genbank: NM_017303) and rat Kv1.2 (Genbank:
NM_012970) and mouse TREK1 (Genbank: NM_010607)
and rat TRAAK (Genbank: NM_053804) were performed
with Effectene transfection reagent (Qiagen). Protocols
were conformed to the product guideline description.
Condition of recording and internal solution was same
with the condition of recording DRG neurons.
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